Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 66


Do hereditary syndrome-related gynecologic cancers have any specific features?

Neto N, Cunha TM.

Insights Imaging. 2015 Oct;6(5):545-52. doi: 10.1007/s13244-015-0425-x. Epub 2015 Sep 4.


Randomized Trial of Telegenetics vs. In-Person Cancer Genetic Counseling: Cost, Patient Satisfaction and Attendance.

Buchanan AH, Datta SK, Skinner CS, Hollowell GP, Beresford HF, Freeland T, Rogers B, Boling J, Marcom PK, Adams MB.

J Genet Couns. 2015 Dec;24(6):961-70. doi: 10.1007/s10897-015-9836-6. Epub 2015 Apr 3.


Comparative effectiveness of screening strategies for Lynch syndrome.

Barzi A, Sadeghi S, Kattan MW, Meropol NJ.

J Natl Cancer Inst. 2015 Mar 20;107(4). pii: djv005. doi: 10.1093/jnci/djv005. Print 2015 Apr.


Clinicopathological and genetic features of Chinese hereditary nonpolyposis colorectal cancer (HNPCC).

Liu F, Yang L, Zhou X, Sheng W, Cai S, Liu L, Nan P, Xu Y.

Med Oncol. 2014 Oct;31(10):223. doi: 10.1007/s12032-014-0223-1. Epub 2014 Sep 13.


Cost-effectiveness and diagnostic effectiveness analyses of multiple algorithms for the diagnosis of Lynch syndrome.

Gould-Suarez M, El-Serag HB, Musher B, Franco LM, Chen GJ.

Dig Dis Sci. 2014 Dec;59(12):2913-26. doi: 10.1007/s10620-014-3248-6. Epub 2014 Jun 24.


An internal performance assessment of CancerGene Connect: an electronic tool to streamline, measure and improve the genetic counseling process.

Pritzlaff M, Yorczyk A, Robinson LS, Pirzadeh-Miller S, Lin T, Euhus D, Ross TS.

J Genet Couns. 2014 Dec;23(6):1034-44. doi: 10.1007/s10897-014-9732-5. Epub 2014 Jun 12.


Evaluation of clinical criteria for the identification of Lynch syndrome among unselected patients with endometrial cancer.

Bruegl AS, Djordjevic B, Batte B, Daniels M, Fellman B, Urbauer D, Luthra R, Sun C, Lu KH, Broaddus RR.

Cancer Prev Res (Phila). 2014 Jul;7(7):686-97. doi: 10.1158/1940-6207.CAPR-13-0359. Epub 2014 Apr 25.


American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers.

Lu KH, Wood ME, Daniels M, Burke C, Ford J, Kauff ND, Kohlmann W, Lindor NM, Mulvey TM, Robinson L, Rubinstein WS, Stoffel EM, Snyder C, Syngal S, Merrill JK, Wollins DS, Hughes KS; American Society of Clinical Oncology.

J Clin Oncol. 2014 Mar 10;32(8):833-40. doi: 10.1200/JCO.2013.50.9257. Epub 2014 Feb 3. No abstract available.


Reclassification of predictions for uncovering subgroup specific improvement.

Biswas S, Arun B, Parmigiani G.

Stat Med. 2014 May 20;33(11):1914-27. doi: 10.1002/sim.6077. Epub 2013 Dec 18.


Hereditary cancer risk assessment: essential tools for a better approach.

Gomy I, Estevez Diz Mdel P.

Hered Cancer Clin Pract. 2013 Oct 28;11(1):16. doi: 10.1186/1897-4287-11-16.


Genetic testing strategies in newly diagnosed endometrial cancer patients aimed at reducing morbidity or mortality from lynch syndrome in the index case or her relatives.

Stewart A Phd.

PLoS Curr. 2013 Sep 16;5. pii: ecurrents.eogt.b59a6e84f27c536e50db4e46aa26309c. doi: 10.1371/currents.eogt.b59a6e84f27c536e50db4e46aa26309c.


PTEN germline mutations in patients initially tested for other hereditary cancer syndromes: would use of risk assessment tools reduce genetic testing?

Mester JL, Moore RA, Eng C.

Oncologist. 2013;18(10):1083-90. doi: 10.1634/theoncologist.2013-0174. Epub 2013 Sep 13.


Familial colorectal cancer, beyond Lynch syndrome.

Stoffel EM, Kastrinos F.

Clin Gastroenterol Hepatol. 2014 Jul;12(7):1059-68. doi: 10.1016/j.cgh.2013.08.015. Epub 2013 Aug 17. Review.


History, genetics, and strategies for cancer prevention in Lynch syndrome.

Kastrinos F, Stoffel EM.

Clin Gastroenterol Hepatol. 2014 May;12(5):715-27; quiz e41-3. doi: 10.1016/j.cgh.2013.06.031. Epub 2013 Jul 23. Review.


Utility of MLH1 methylation analysis in the clinical evaluation of Lynch Syndrome in women with endometrial cancer.

Bruegl AS, Djordjevic B, Urbauer DL, Westin SN, Soliman PT, Lu KH, Luthra R, Broaddus RR.

Curr Pharm Des. 2014;20(11):1655-63.


Providing access to risk prediction tools via the HL7 XML-formatted risk web service.

Chipman J, Drohan B, Blackford A, Parmigiani G, Hughes K, Bosinoff P.

Breast Cancer Res Treat. 2013 Jul;140(1):187-93. doi: 10.1007/s10549-013-2605-z. Epub 2013 Jun 23.


Adrenocortical carcinoma is a lynch syndrome-associated cancer.

Raymond VM, Everett JN, Furtado LV, Gustafson SL, Jungbluth CR, Gruber SB, Hammer GD, Stoffel EM, Greenson JK, Giordano TJ, Else T.

J Clin Oncol. 2013 Aug 20;31(24):3012-8. doi: 10.1200/JCO.2012.48.0988. Epub 2013 Jul 22. Erratum in: J Clin Oncol. 2013 Oct 1;31(28):3612.


Perceived versus predicted risks of colorectal cancer and self-reported colonoscopies by members of mismatch repair gene mutation-carrying families who have declined genetic testing.

Flander L, Speirs-Bridge A, Rutstein A, Niven H, Win AK, Ait Ouakrim D, Hopper JL, Macrae F, Keogh L, Gaff C, Jenkins M.

J Genet Couns. 2014 Feb;23(1):79-88. doi: 10.1007/s10897-013-9614-2. Epub 2013 Jun 9.


Identification of patients at risk for hereditary colorectal cancer.

Mishra N, Hall J.

Clin Colon Rectal Surg. 2012 Jun;25(2):67-82. doi: 10.1055/s-0032-1313777.


Simplifying clinical use of the genetic risk prediction model BRCAPRO.

Biswas S, Atienza P, Chipman J, Hughes K, Barrera AM, Amos CI, Arun B, Parmigiani G.

Breast Cancer Res Treat. 2013 Jun;139(2):571-9. doi: 10.1007/s10549-013-2564-4. Epub 2013 May 21.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk